Plus: Two Russian ballistic missiles hit a military institute and a hospital in central Ukraine. The European Court of Justice said the EU’s competition authority lacked jurisdiction when it reviewed U.S. gene-sequencing company Illumina’s takeover of cancer-test maker Grail. J.R. Whalen reports.

Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices